PETER KIENER

Profile

First Name

: PETER

Middle Name

:

Last Name

: KIENER

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
ZYNGENIA, INC.
JOSEPH AMPREY, CARLOS BARBAS, CARLOS F. BARBAS, III, ROBERT GARLAND, DAVID HILBERT, PETER A. KIENER, DANIEL MENICHELLA, DAVID MOTT, SCOTT MOTT, DAVID PARKINSON
EXECUTIVE OFFICER
RESOLVE THERAPEUTICS LLC
JAMES POSADA, SOMU SUBRAMANIAM
DIRECTOR
CUE BIOPHARMA, INC.
STEVEN ALMO, DANIEL BAKER, JILL M. BROADFOOT, RODOLFO CHAPARRO, ANTHONY DIGIANDOMENICO, FREDERICK DRISCOLL, AARON FLETCHER, PAMELA D. GARZONE, CAMERON GRAY, TAMAR HOWSON, PETER A. KIENER, SHAO-LEE LIN, CHRISTOPHER MARLETT, STEVEN MCKNIGHT, KERRI-ANN MILLAR, FRANK MORICH, PATRICIA NASSHORN, DANIEL PASSERI, DANIEL R. PASSERI, KEN PIENTA, COLIN SANDERCOCK, COLIN G. SANDERCOCK, PASHA SARRAF, GARY SCHUMAN, RONALD SEIDEL III, BARRY SIMON, ANISH SURI, PATRICK VERHEYEN, AMY WANG
DIRECTOR
TETRAGENETICS INC
ELLEN BARON, MARCO CACCIUTTOLO, THEODORE CLARK, MARC FRANZMAN, ROBERT GAILUS, WILLIAM E GORDON, MARTIN GOROVSKY, DANIEL GRAU, R DOUGLAS KAHN, R. DOUGLAS KAHN, R. DOUGLASS KAHN, BEN MACHIELSE, KEVIN O-BRIEN, JOHN REILLY, CHRISTOPHER TARON, ALISON TAUNTON-RIGBY
DIRECTOR
GT BIOPHARMA, INC.
JON BONFIGLIO, MICHAEL BREEN, CHARLES CASAMENTO, ANTHONY CATALDO, ANTHONY J. CATALDO, KATHLEEN CLARENCE-SMITH, GEOFFREY B. DAVIS, ANSHUMAN DUBE, KENNETH EATON, HILARY KRAMER, ANDREW RITTER, DAVID SALOFF, RAJESH SHROTRIYA, ALAN URBAN, RAYMOND URBANSKI, STEVEN WELDON, BRUCE WENDEL
DIRECTOR
WUGEN, INC.
MATTHEW COOPER, JAN K DAVIDSON, DREW DENNISON, BOSUN HAU, AYMAN KABAKIBI, DANIEL M KEMP, KEVIN LI, JOHN P MCKEARN, JOHN P. MCKEARN, NATALIE MOUNT, BALI MURALIDHAR, NIALL O-DONNELL, KUMAR SRINIVASAN, CHERRY THOMAS, KEITH VENDOLA
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2026-05-04 
2025-09-08
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-22 
2021-07-23
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-13 
2021-07-23
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-09 
2020-09-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-09-19 
2018-08-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-08-02 
2018-07-19
D
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2018-06-29 
2017-03-01
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2017-02-21 
2016-12-30
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2016-12-22 
2016-12-22
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2016-12-22 
2013-01-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-02 
2012-04-25
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2012-04-09 
2011-05-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-09 
2009-10-09
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-25